Wind data shows that as of August 25, since the second half of this year, insurance companies and insurance asset management companies have investigated 259 A-share listed companies, an increase of 27.59% over the same period last year. Among them, the company that has received the most attention from insurance companies and insurance asset management companies is 000661, a leading growth hormone company, which has received 29 surveys.

Since the second half of the year, 62 companies on the ChiNext and 42 companies on the Science and Technology Innovation Board have received surveys from insurance companies and insurance asset management companies. A large insurance funder told reporters: "Compared with the main board, the Sci-tech Innovation Board and GEM listed companies have more growth potential, and insurance asset management is increasing its investment and research coverage in this field."

In terms of different industries, electronic components, industrial machinery, and medical care have a relatively high rate of appearance. 22, 19, and 14 listed companies were surveyed, covering many leading stocks in the industry. These include 002241, the leader in Apple's industrial chain, 002402, the leader in intelligent controllers, 300751, the leader in photovoltaic heterojunction equipment, and 300171, the leader in biopharmaceutical equipment.

It can be seen from the research style that in the second half of the year, insurance funds prefer growth industries.